FDA Approves Onswik: A Once-Weekly Insulin For Adults With Type 2 Diabetes
If you live with type 2 diabetes (T2D) and find the frequency of multiple daily injections (MDI) dauntinghere’s a bit of good news: Eli Lilly announced the Food and Drug…
If you live with type 2 diabetes (T2D) and find the frequency of multiple daily injections (MDI) dauntinghere’s a bit of good news: Eli Lilly announced the Food and Drug…
The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with type 2 diabetes (T2D). This…
DreaMed Diabetes has received FDA 510(K) clearance for MODI, a tool that uses continuous glucose monitoring data to provide insulin dosing recommendations for people with Type 2 diabetes who need…
September 24, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
Health 8 sources·Updated Sep 24, 2026 The U.S. Food and Drug Administration on Thursday, Sept. 24, 2026, approved Eli Lilly’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults…
FDA approved of Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin indicated along with diet and exercise to control high blood sugar in adults with type 2 diabetes. With FDA’s…
September 17, 2026 1 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
The FDA expanded the approval for teplizumab (Tzield), a biologic that delays the progression of preclinical type 1 diabetes to the symptomatic form, to include treatment in kids as young…
Breakthrough T1DTzield approved for children ages one and older in stage 2 T1DThe U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type…
The U.S. Food & Drug Administration announced that a glucose meter (a.k.a. a blood sugar meter) company is issuing an important correction for its blood glucose monitoring system.True Metrix is…